MHCombiotic
Calgary-based biotech focused on discovery and development of antimicrobial solutions that target biofilms and drug-resistant pathogens. The company develops plant‑based antibacterial agents and formulation platforms for wound care, respiratory, and systemic (sepsis) indications, and advances candidates through preclinical validation, regulatory testing, and phased clinical development. Activities include large-scale formulation screening, multi-omics characterization, laboratory validation in regulatory-authority-approved labs, patenting, and partnership outreach.
Industries
Nr. of Employees
small (1-50)
Products
Antimicrobial hydrogel wound dressing and irrigation formulation
Hydrated barrier hydrogel and complementary irrigation solution formulated to maintain wound moisture, support cleansing, reduce dressing-change trauma, and limit microbial growth within dressings.
Inhaled antimicrobial and anti-inflammatory therapeutic candidate for respiratory infections
Therapeutic approach intended to provide broad-spectrum antimicrobial and anti-inflammatory activity for respiratory infections, including antibiofilm and antioxidant effects to support lung health.
Systemic antimicrobial therapeutic candidate for sepsis
Therapeutic candidate aimed at addressing systemic infections and sepsis by combining broad-spectrum antimicrobial activity with modulation of inflammation and oxidative stress.
Antimicrobial hydrogel wound dressing and irrigation formulation
Hydrated barrier hydrogel and complementary irrigation solution formulated to maintain wound moisture, support cleansing, reduce dressing-change trauma, and limit microbial growth within dressings.
Inhaled antimicrobial and anti-inflammatory therapeutic candidate for respiratory infections
Therapeutic approach intended to provide broad-spectrum antimicrobial and anti-inflammatory activity for respiratory infections, including antibiofilm and antioxidant effects to support lung health.
Systemic antimicrobial therapeutic candidate for sepsis
Therapeutic candidate aimed at addressing systemic infections and sepsis by combining broad-spectrum antimicrobial activity with modulation of inflammation and oxidative stress.
Expertise Areas
- Antimicrobial discovery and preclinical development
- Biofilm disruption and antibiofilm strategies
- Wound care device formulation
- Respiratory and systemic infection therapeutics
Key Technologies
- Multi-omics analysis
- Probe-based biochemical assays
- High-throughput formulation screening
- Hydrated hydrogel wound dressings